Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

LUSTENAU, Austria, March 3 /PRNewswire/ -- IDENTEC SOLUTIONS groundbreaking Intelligent Long Range (ILR) RFID technology is playing an instrumental role in the construction of the monumental Freedom Tower located at the World Trade Center site in downtown Manhattan. Construction of the 1,776 foot tower has been underway since April of 2006 with an anticipated opening sometime in 2011.

MILTON KEYNES, England, March 3 /PRNewswire/ -- Some of the most contentious moral issues of today's society are the focus of Ethics Bites - a new series of podcasts from The Open University that features contributions from some of the most eminent commentators in the field drawn from across the world.

The latest thinking on issues as diverse as climate change, euthanasia, censorship of the arts and corporate responsibility is drawn together for the series, the first podcasts of which are now available at open2.net (http://www.open2.net?LKCAMPAIGN=PR03).

Applied ethics is a central theme; at the core of each programme in the 14-part series are the connections between the issue and its everyday implications.

LONDON, March 3 /PRNewswire/ --

Global IP solutions provider Global Crossing (Nasdaq: GLBC) today announced that HM Revenue & Customs (HMRC) will employ Global Crossing's hosted IP telephony service for the operation of all its telephony services across the UK, supporting 85,000 users. The service will be provided through an OGCbuying.solutions contract. HMRC staff throughout the UK will gradually migrate to this secure, hosted IP telephony service.

LONDON, March 3 /PRNewswire/ -- In video interviews, Marjorie Scardino, CEO, and Robin Freestone, FD, discuss Pearson's preliminary results and why they remain confident about the group's prospects. There will also be a live analyst presentation at 09:00GMT followed by a US conference call at 15:00GMT. The interviews, transcripts, podcasts and vodcasts are available now on http://www.cantos.com.

It's free to view. All you need to do is register at http://www.cantos.com. Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email enquiries@cantos.com or phone +44(0)207-936-1333.

DENVER, March 3 /PRNewswire/ --

- World-Renowned Pain Management Expert Robin Downing, DVM, Will Conduct Webcast For Pet Owners and Veterinarians, Covering All Aspects Related to Pets and Pain. These Two Individual Presentations Can Be Viewed On Web Site.

BASEL, Switzerland, March 3 /PRNewswire/ -- Physicians from countries worst-affected by the deadly bird flu (H5N1 influenza virus) have reported an increased survival rate in patients treated with the oral antiviral Tamiflu (oseltamivir). These data reinforce the World Health Organization (WHO) advisory that Tamiflu is the only antiviral strongly recommended for the treatment of humans infected with the H5N1 virus. The physicians' report was revealed this week at the International Symposium on Respiratory Viral Infections (ISRVI) in Singapore.(1)

According to the WHO the H5N1 virus has already killed 234 people in 12 countries.(2) Tamiflu is the only antiviral reported to have been used against H5N1 in humans outside the laboratory and actually in the field.